| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447312 | European Journal of Cancer | 2011 | 9 Pages |
Abstract
These data indicate that low expression of LMNA is associated with an increased disease recurrence in stage II and III colon cancer patients, and suggest that these patients in particular may benefit from adjuvant chemotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
E.J.Th. Belt, R.J.A. Fijneman, E.G. van den Berg, H. Bril, P.M. Delis-van Diemen, M. Tijssen, H.F. van Essen, E.S.M. de Lange-de Klerk, J.A.M. Beliën, H.B.A.C. Stockmann, S. Meijer, G.A. Meijer,